Related Experiment Videos
Pediatric fungal infections from head to toe: what's new?
1New England Medical Center Hospital, Boston, Massachusetts.
Abstract:
This review highlights recent advances in the epidemiology, diagnosis, treatment, and pathophysiology of cutaneous fungal infections in childhood, from tinea capitis to tinea pedis. Emphasis is placed on a practical approach to caring for children with superficial fungal infections. New antifungal agents are reviewed and their potential importance discussed. Brief mention is made of some ordinarily benign cutaneous fungal pathogens that may, in some settings, cause systemic infections.
Insights
This review covers childhood fungal skin infections, including epidemiology, diagnosis, and treatment. It emphasizes practical care and discusses new antifungal drugs, noting potential systemic infections from common pathogens.
Area of Science:
- Pediatric Dermatology
- Mycology
Background:
- Childhood cutaneous fungal infections are common, ranging from tinea capitis to tinea pedis.
- Effective management requires understanding their epidemiology, pathophysiology, and current treatment options.
Purpose of the Study:
- To review recent advances in the understanding and management of pediatric superficial fungal infections.
- To provide a practical approach for clinicians caring for children with these conditions.
- To discuss emerging antifungal therapies and potential risks.
Main Methods:
- Literature review of recent studies on childhood fungal skin infections.
- Synthesis of information on epidemiology, diagnosis, pathophysiology, and treatment.
- Evaluation of new antifungal agents and their clinical relevance.
Main Results:
- Advances in understanding the epidemiology and pathophysiology of common pediatric mycoses.
- Updated diagnostic strategies and treatment guidelines for tinea infections.
- Review of novel antifungal agents and their potential role in pediatric care.
Conclusions:
- A practical, evidence-based approach is crucial for managing childhood fungal skin infections.
- New antifungal agents offer promising therapeutic options.
- Awareness of potential systemic infections from superficial fungal pathogens is important in specific contexts.